EMA starts rolling review of Covid-19 HIPRA's vaccine | HIPRA
EU experts cautious on fourth dose of COVID-19 - Medical Update Online
EMA and ECDC publish advice on fourth doses of mRNA COVID-19 vaccines - PMLiVE
Too early' for fourth Covid vaccine dose for general population, says EMA
'Too early' for fourth Covid vaccine dose for general population
EMA advises on intradermal use of Imvanex / Jynneos against monkeypox | CDE Almería - Centro de Documentación Europea - Universidad de Almería
Coronavirus vaccination: the most important questions and answers
EMA press briefing 4 November 2021 - YouTube
COVID vaccines: It's too early to consider giving people a fourth dose, say EU officials | Euronews
COVID: Lack of science behind frequent boosting – DW – 01/18/2022
European Regulator Gives Approval to Johnson & Johnson One-Shot Vaccine
Reactions to Pfizer executive's claim that they did not test whether covid-19 vaccines stopped transmission
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
EMA-ECDC 4th dose statement - Edited tracked changes_final_clean
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
4.1 Update on vaccines and therapeutics - M Cavaleri (EMA)
ECDC & EMA Conclude That It Is Too Early to Consider Using Fourth Dose of COVID-19 Vaccines - SchengenVisaInfo.com
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines
Latest updates on COVID-19 vaccines: EMA, Moderna, Novavax | EATG
EU members question fourth dose, except most vulnerable – EURACTIV.com
EMA press briefing 18 January 2022 - YouTube
News - Committee for Medicinal Products for Human Use (CHMP) Recommends Conditional Marketing Authorisation of the COVID-19 Vaccine by Janssen-Cilag International N.V. - Paul-Ehrlich-Institut
ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines
EU Medicines Agency on Twitter: "EMA has started evaluating the use of a #booster dose of #Novavax's #COVID19vaccine, Nuvaxovid, in adults. 👇" / Twitter
